FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:122-123 January 11, 1996 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pathmanathan, R.

To the Editor: The thought-provoking results of Pathmanathan et al. (Sept. 14 issue)¹ concerning the role of Epstein–Barr virus (EBV) in nasopharyngeal cancer are of great interest and may have therapeutic implications, especially in areas of the world where the disease is endemic. There is, however, one point I would like clarified.

Do the investigators hold that the only evolutionary path for nasopharyngeal cancer is through infection of an epithelial stem cell followed by transformation, clonal expansion, and development into metastatic cancer? From their study, this would seem to be the case, since the episomal EBV DNA in each case . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.